Aran Research & Development (1982) Ltd.

Aran Research & Development (1982) Ltd.

TTASE:ARAN
4,541.00
ILA
+47.00
(+1.05%)
11.02BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
21.38
18.66
23.56
19.56
29.08
28.19
23.38
19.65
41.91
35.37
35.19
44.62
57.7
- -
Basic EPS, GAAP
3.59
0.22
0.78
0.87
1.32
1.86
0.48
0.62
2.24
4.81
3.29
1.4
4.09
- -
Free Cash Flow per Basic Share
-3.88
-1.62
1.2
-1.06
4.34
-3.31
0.51
5.13
-5.14
-11.24
-0.2
7.3
12.5
- -
Dividend per Share
1
0.5
0.5
0.5
1.41
0.2
0.87
- -
0.61
0.61
1.23
- -
3.08
- -
Book Value per Share
- -
10.61
10.79
11.13
10.34
11.84
11.45
12.02
13.65
17.76
19.85
21.31
20.94
13.36
Tangible Book Value per Share
- -
9.64
9.65
9.98
8.89
10.08
9.75
10.64
12.66
17.55
17.08
18.97
19
12.14
Basic Weighted Avg Shares
4
5
5
5
5
5
5
5
5
5
5
5
5
5
Sales/Revenue/Turnover
95
84
115
95
142
138
114
96
205
173
172
218
263
- -
Operating Margin (%)
36.15
4.14
2.05
-0.63
2.58
5.05
0.3
2.68
5.95
4.32
-2.38
4.35
6.06
- -
Depreciation Expense
2
2
3
3
3
3
6
6
6
4
5
8
8
- -
Net Income, GAAP
16
1
4
4
6
9
2
3
11
23
16
7
19
- -
Effective Tax Rate (%)
25.57
28.79
12.29
5.28
15.93
16.03
- -
13.41
20.6
28.28
15.17
22.94
22.5
- -
Profit Margin (%)
16.77
1.21
3.32
4.43
4.55
6.58
2.04
3.14
5.34
13.6
9.36
3.13
7.09
- -
Working Capital
- -
19
22
24
22
22
19
27
55
75
76
84
80
38
LT Debt
- -
- -
9
8
7
6
13
15
57
72
33
19
16
27
Total Equity
- -
54
55
55
53
60
58
60
68
89
102
109
105
67
Return on Invested Capital (%)
- -
- -
4.71
4
7.72
8.29
- -
2.75
7.9
13.75
2.35
4.58
17.92
- -
Return on Capital (%)
- -
- -
6.41
8.04
10.07
14.14
- -
4.52
9.89
11.31
8.73
4.81
9.22
- -
Return on Common Equity (%)
- -
- -
7.32
7.92
12.33
16.74
4.1
5.25
17.45
30.62
17.51
6.78
18.8
- -

Capital Structure

ILS

•

in mil. unless spec.
Sep'20
Dec'20
Jun'21
ST Debt
- -
17
19
LT Borrowings
- -
8
21
LT Finance Leases
- -
7
6
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
60
88
110

Working Capital

ILS

•

in mil. unless spec.
Sep'20
Dec'20
Jun'21
Total Current Assets
- -
100
112
Cash, Cash Equivalents & STI
- -
50
53
Accounts Receivable, Net
- -
30
46
Inventories
- -
3
4
Total Current Liabilities
- -
74
75
Payables & Accruals
- -
- -
- -
ST Debt
- -
17
19
Deferred Revenue
- -
- -
- -

Growth Rates

ILS

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.22%
12.31%
-3.21%
Free Cash Flow
-386.43%
-756.6%
59.99%
Net Income, GAAP
52.21%
92.65%
174.16%
Sales/Revenue/Turnover
14.09%
28.96%
20.81%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

ILS

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
172
2024
- -
- -
218
2025
- -
- -
263

Semi-annual Earnings Per Share

ILS

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
3.29
2024
- -
- -
1.4
2025
- -
- -
4.09

Semi-annual Dividends Per Share

ILS

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1.23
2024
- -
- -
- -
2025
- -
- -
3.08

Company Description

CEO
Ran Stav
Full Time Employees
249
Sector
Distribution services
Industry
Wholesale distributors
Address
Caesarea Business Park Caesarea HA Israel 3088900
IPO Date
Aug 1, 2000
Business
Aran Research & Development (1982) Ltd. (ARAN.TA) is an Israel-based product design, development and manufacturing firm that specializes in high-tech solutions across medical devices, water and fluid management systems, defense and homeland security technologies, consumer and industrial products, and equipment for the plastics industry. Founded in 1982 and headquartered in Caesarea, the company provides comprehensive product development services including industrial design, mechanical and electronics engineering, rapid prototyping via 3D printing and CNC machining, and full-scale production; it develops medical devices such as cardiovascular interventional systems, in-vitro diagnostics, surgical instruments, imaging and monitoring equipment; water devices encompassing pressure and flow regulators, electric and hydraulic valves, air release valves, sprinklers, drippers, taps, water meters, filters, check valves, electronic controllers and testing devices; defense products like portable and stationary control stations for unmanned systems, electro-optics, rugged electronics for ground, marine and aerial platforms, access control systems, test equipment and production facilities; consumer and industrial offerings including measurement and weighing devices, specialty printers, automatic beverage machines, computerized shopping carts, self-checkout kiosks, industrial communication devices and batteries; and plastics industry equipment such as injection molding machines from ENGEL, robotics and automation from ENGEL and STAR, injection molds, hot runner systems from YUDO and HEITEC, drying, dosing and conveying systems from PIOVAN, plasticizing screws and barrels, ultrasonic welding and cleaning systems, plus raw materials from EXXON MOBIL and CABOT. Aran operates primarily in Israel with a focus on domestic and international markets in these sectors, serving clients from startups to multinational corporations, and maintains investments in medical startups including ongoing projects like the GoBack Catheter from Upstream Peripheral Technologies and Endoaid Ltd. for gastrointestinal endoscopy. In recent developments, the company continues to leverage its expertise in 3D printing and advanced manufacturing, as demonstrated by its support for student engineering projects and community initiatives in robotics and Formula SAE racing components, while sustaining its role as an exclusive agent for global plastics equipment leaders amid steady operations on the Tel Aviv Stock Exchange.